Article 4A Movement of certain medicinal products to the United States of AmericaF1
United Kingdom
Subject to articles 17 and 26, no person shall export a human or veterinary medicinal product containing the active ingredient pancuronium bromide F2or propofol where—
the product is in a form suitable for injection or for preparation of an injection; and
paragraph (2) or (3) applies.
This paragraph applies where the destination of the product is the United States of America.
This paragraph applies where the destination is not the United States of America but the exporter knows that the final destination of the product is the United States of America.
Annotations
Textual amendments
- F1
Art. 4A inserted (16.4.2012) by The Export Control (Amendment) Order 2012 (S.I. 2012/929), arts. 1, 3(2)
- F2
Words in art. 4A(1) inserted (10.8.2012) by The Export Control (Amendment) (No. 2) Order 2012 (S.I. 2012/1910), arts. 1, 2, Sch. para. 3
Notes on Part 2
Modifications
- C1
Pt. 2 excluded (20.2.2010) by The Export Control (Guinea) Order 2010 (S.I. 2010/364), arts. 1(1), 5